| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33023440_HAS_TOPIC_C0034424> <https://research.tib.eu/covid-19/entity/33023440_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33023440_HAS_TOPIC_C0887920> <https://research.tib.eu/covid-19/entity/33023440_HAS_TOPIC_C0920472> <https://research.tib.eu/covid-19/entity/33023440_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33023440_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33023440_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Laboratorio de Biologia Celular, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Soeiro_Maria_N_C> <https://research.tib.eu/covid-19/entity/da_Gama_Aline_N_Silva>
?:doi	10.2174/1381612826666201006125644
?:doi	<https://research.tib.eu/covid-19/entity/10.2174/1381612826666201006125644>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Current pharmaceutical design
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33023440> <https://research.tib.eu/covid-19/entity/wjz1csey>
?:pmid	<https://research.tib.eu/covid-19/entity/33023440>
?:pmid	33023440
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.883
?:rankingScore_hIndex	136
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0003392_TREATS_C0004364> <https://research.tib.eu/covid-19/entity/C0718566_TREATS_C0004364> <https://research.tib.eu/covid-19/entity/C1336827_PROCESS_OF_C0041221> <https://research.tib.eu/covid-19/entity/C1424276_CAUSES_C0023281> <https://research.tib.eu/covid-19/entity/C1424276_CAUSES_C0041228> <https://research.tib.eu/covid-19/entity/C1424276_CAUSES_C0041234> <https://research.tib.eu/covid-19/entity/C1424276_PART_OF_C0041217>
?:title	Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33023440>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33023440>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all